Marfan syndrome
Updates to Article Attributes
Marfan syndrome is a multisystem connective tissue disease caused by a defect in the protein fibrillin 1, encoded for by the FBN1 gene. Cardiovascular involvement with aortic root dilatation and dissection is the most feared complication of the disease.
Epidemiology
The estimated prevalence is around 2-6 per 100,000 2,5. There is no recognised gender or racial predilection.
Clinical presentation
Patients with Marfan syndrome may have the following symptoms and signs on history and examination:
- general
- tall stature
- long arm
-spanspan (often exceeding the height of the patient) - joint laxity resulting in recurrent dislocations
- spine/skull
- hands
- arachnodactyly
- protrusion of thumb beyond fist when clenched (Steinberg sign)
- flexion deformity of the
5little fingerthfinger
- pelvis / lower limbs
- chest wall deformities (present in up to
2/3⅔ of cases 2)rdsof - ocular
- cardiovascular
-
aortic regurgitation or mitral regurgitation
on auscultation
-
aortic regurgitation or mitral regurgitation
Patients may present with complications of the disease such as, aortic dissection and pneumothorax.
Diagnostic criteria
TheGhent nosology was established in 1995 for the clinical diagnosis of the disease 7.
Pathology
Genetics
The condition is thought to resultresults from an inherited or de novoa mutation in the fibrillin 1 (FBN1) gene located on chromosome 15q21.1 which is responsible for cross-linking collagen. In the majority of cases it is inherited in an autosomal dominant fashion, although in up to one-third of cases the mutation is de novo. The disease has high genetic penetrance but with variable phenotypic expression even amongst affected family members.
Studies show a regulatory relationship between extracellular microfibrils and TGFβ signalling, so an abnormality in either can cause a Marfanoid phenotype 9.
Microscopic appearance
Microscopically the arterial walls may show cystic medial necrosis 10.
Radiographic features
There are no specific radiographic features of Marfan syndrome but the following signs and complications of the disease may be seen in each system on a range of modalities:
Skeletal
- general
- osteopenia 1
- joint dislocation
- spine/skull
- pelvis / lower limbs
- hands
- arachnodactyly
- protrusion of thumb beyond fist when clenched (Steinberg sign)
- flexion deformity of the
5little finger(s)thfinger
- chest wall deformities
Cardiovascular
- aortic root dilatation and myxomatous degeneration of the mitral valve resulting in mitral valve regurgitation are the most two common cardiac manifestations 9
-
aortic aneurysm and aortic dissection are the most fearsome consequences - findings suggestive of higher risk of aortic dissection are:
- family history of aortic dissection
- dilatation at the aortic sinotubular junction
- aortic root diameter >
; 55;55 mm - increased aortic stiffness
- excessive aortic root dilatation (>1.7 mm/year)
- arterial dissection
- aortic valve regurgitation (AR)
- aortic coarctation
- pulmonary arterial dilatation
Pulmonary
- spontaneous pneumothorax
- lung cysts and bullae formation
Treatment and prognosis
Beta blockers are shown to reduce the rate of aortic root dilatation. In patients who can not take beta-blockers, calcium-channel blockers are used. More recently, investigators found that angiotensin receptor blockers which are also TGFβ antagonists significantly reduce cardiovascular and other somatic features 9. Cardiovascular complications are the most frequent cause of death 2.
Some of the more newer treatment options include.
- personalised external aortic root support (PEARS) procedure
History and etymology
First described in 1896 by Antoine Bernard-Jean Marfan, French paediatrician (1858-1942).
Differential diagnosis
Consider
-
patientscongenital contractural arachnodactyly: has significant phenotypic overlap with Marfan syndrome, but is now considered a discrete entity, due to distinct genetics 11 -
Loeys-Dietz syndrome
have similar: similar features to Marfan syndrome -
patients withhomocystinuria: may resemble those with Marfan syndrome in some aspects 8;ectopia lentis, however, is downward as opposed to Marfan and intellectual disability is also a common feature -
patients withmultiple endocrine neoplasia type IIb may have a Marfan syndrome like body habitus -
patients withBeals syndromehave some features of Marfan syndrome
-<p><strong>Marfan syndrome</strong> is a multisystem <a href="/articles/hereditary-connective-tissue-disease">connective tissue disease</a> caused by a defect in the protein fibrillin 1, encoded for by the FBN1 gene. Cardiovascular involvement with aortic root dilatation and <a href="/articles/aortic-dissection">dissection</a> is the most feared complication of the disease.</p><h4>Epidemiology</h4><p>The estimated prevalence is around 2-6 per 100,000 <sup>2,5</sup>. There is no recognised gender or racial predilection.</p><ul></ul><h4>Clinical presentation</h4><p>Patients with Marfan syndrome may have the following symptoms and signs on history and examination:</p><ul>- +<p><strong>Marfan syndrome</strong> is a multisystem <a href="/articles/hereditary-connective-tissue-disease">connective tissue disease</a> caused by a defect in the protein fibrillin 1, encoded for by the <em>FBN1</em> gene. Cardiovascular involvement with aortic root dilatation and <a href="/articles/aortic-dissection">dissection</a> is the most feared complication of the disease.</p><h4>Epidemiology</h4><p>The estimated prevalence is around 2-6 per 100,000 <sup>2,5</sup>. There is no recognised gender or racial predilection.</p><ul></ul><h4>Clinical presentation</h4><p>Patients with Marfan syndrome may have the following symptoms and signs:</p><ul>
-<li>long arm-span (often exceeding the height of the patient)</li>- +<li>long arm span (often exceeding the height of the patient)</li>
-<li>flexion deformity of the 5<sup>th</sup> finger</li>- +<li>flexion deformity of the little finger</li>
-<li>chest wall deformities (present in up to 2/3<sup>rds</sup> of cases <sup>2</sup>)<ul>- +<li>chest wall deformities (present in up to ⅔ of cases <sup>2</sup>)<ul>
-<li>myopia</li>- +<li><a href="/articles/myopia">myopia</a></li>
-<a href="/articles/aortic-valve-regurgitation">aortic regurgitation</a> or <a href="/articles/mitral-valve-regurgitation">mitral regurgitation</a> on auscultation</li></ul>- +<a href="/articles/aortic-valve-regurgitation">aortic regurgitation</a> or <a href="/articles/mitral-valve-regurgitation">mitral regurgitation</a>
- +</li></ul>
-</ul><p>Patients may present with complications of the disease such as, <a href="/articles/aortic-dissection">aortic dissection</a> and <a href="/articles/pneumothorax">pneumothorax</a>.</p><h5>Diagnostic criteria</h5><p>The<strong> </strong>Ghent nosology was established in 1995 for the clinical diagnosis of the disease <sup>7</sup>.</p><h4>Pathology</h4><p>The condition is thought to result from an inherited or de novo mutation in the fibrillin 1 (<em>FBN1</em>) gene located on chromosome 15q21.1 which is responsible for cross-linking collagen. In the majority of cases it is inherited in an autosomal dominant fashion, although in up to one-third of cases the mutation is de novo. The disease has high genetic penetrance but with variable phenotypic expression even amongst affected family members.</p><p>Studies show a regulatory relationship between extracellular microfibrils and TGFβ signalling, so an abnormality in either can cause a Marfanoid phenotype <sup>9</sup>.</p><h5>Microscopic appearance</h5><p>Microscopically the arterial walls may show cystic medial necrosis <sup>10</sup>.</p><h4>Radiographic features</h4><p>There are no specific radiographic features of Marfan syndrome but the following signs and complications of the disease may be seen in each system on a range of modalities:</p><h5>Skeletal</h5><ul>- +</ul><p>Patients may present with complications of the disease such as, <a href="/articles/aortic-dissection">aortic dissection</a> and <a href="/articles/pneumothorax">pneumothorax</a>.</p><h5>Diagnostic criteria</h5><p>The<strong> </strong>Ghent nosology was established in 1995 for the clinical diagnosis of the disease <sup>7</sup>.</p><h4>Pathology</h4><h5>Genetics</h5><p>The condition results from a mutation in the fibrillin 1 (<em>FBN1</em>) gene located on chromosome 15q21.1 which is responsible for cross-linking collagen. In the majority of cases it is inherited in an autosomal dominant fashion, although in up to one-third of cases the mutation is de novo. The disease has high genetic penetrance but with variable phenotypic expression even amongst affected family members.</p><p>Studies show a regulatory relationship between extracellular microfibrils and TGFβ signalling, so an abnormality in either can cause a Marfanoid phenotype <sup>9</sup>.</p><h5>Microscopic appearance</h5><p>Microscopically the arterial walls may show cystic medial necrosis <sup>10</sup>.</p><h4>Radiographic features</h4><p>There are no specific radiographic features of Marfan syndrome but the following signs and complications of the disease may be seen in each system on a range of modalities:</p><h5>Skeletal</h5><ul>
-<a title="tibial subluxation" href="/articles/tibial-subluxation">tibial subluxation</a> <sup>5</sup>- +<a href="/articles/tibial-subluxation">tibial subluxation</a> <sup>5</sup>
-<li>flexion deformity of the 5<sup>th</sup> finger</li>- +<li>flexion deformity of the little finger(s)</li>
-<li>aortic root diameter > 55 mm</li>- +<li>aortic root diameter >55 mm</li>
-<a href="/articles/personalised-external-aortic-root-support-pears">personalised external aortic root support</a> (PEARS) procedure</li></ul><h4>History and etymology</h4><p>First described in 1896 by <strong>Antoine Bernard-Jean Marfan</strong>, French paediatrician (1858-1942).</p><h4>Differential diagnosis</h4><p>Consider</p><ul>-<li>patients with <a href="/articles/loeys-dietz-syndrome-2">Loeys-Dietz syndrome </a>have similar features to Marfan syndrome</li>-<li>patients with <a href="/articles/homocystinuria">homocystinuria</a> may resemble those with Marfan syndrome in some aspects<sup> 8</sup>;<sup> </sup>ectopia lentis, however, is downward as opposed to Marfan and intellectual disability is also a common feature</li>-<li>patients with <a href="/articles/multiple-endocrine-neoplasia-type-iib">multiple endocrine neoplasia type IIb</a> may have a Marfan syndrome like body habitus </li>-<li>patients with <a href="/articles/beals-syndrome-2">Beals syndrome</a> have some features of Marfan syndrome</li>- +<a href="/articles/personalised-external-aortic-root-support-pears">personalised external aortic root support (PEARS)</a> procedure</li></ul><h4>History and etymology</h4><p>First described in 1896 by <strong>Antoine Bernard-Jean Marfan</strong>, French paediatrician (1858-1942).</p><h4>Differential diagnosis</h4><ul>
- +<li>
- +<a href="/articles/congenital-contractural-arachnodactyly-1">congenital contractural arachnodactyly</a>: has significant phenotypic overlap with Marfan syndrome, but is now considered a discrete entity, due to distinct genetics <sup>11</sup>
- +</li>
- +<li>
- +<a href="/articles/loeys-dietz-syndrome-2">Loeys-Dietz syndrome</a>: similar features to Marfan syndrome</li>
- +<li>
- +<a href="/articles/homocystinuria">homocystinuria</a>: may resemble those with Marfan syndrome in some aspects<sup> 8</sup>;<sup> </sup><a title="Ectopia lentis" href="/articles/ectopia-lentis">ectopia lentis</a>, however, is downward as opposed to Marfan and intellectual disability is also a common feature</li>
- +<li>
- +<a href="/articles/multiple-endocrine-neoplasia-type-iib">multiple endocrine neoplasia type IIb</a> may have a Marfan syndrome like body habitus</li>
References changed:
- 11. Tunçbilek E, Alanay Y. Congenital contractural arachnodactyly (Beals syndrome). (2006) Orphanet journal of rare diseases. 1: 20. <a href="https://doi.org/10.1186/1750-1172-1-20">doi:10.1186/1750-1172-1-20</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/16740166">Pubmed</a> <span class="ref_v4"></span>